Abstract | Background: Methods: We analyzed clinical, imaging, and pathology findings of all patients with NF1 and ANF at 3 institutions. Results: Sixty-three patients had 76 ANF (32M/31F; median age 27.1 y). On MRI, most ANF appeared as distinct nodular lesions and were 18F-fluorodeoxyglucose (FDG) avid. Forty-six ANF were associated with pain, 19 with motor weakness, 45 were palpable or visible, and 13 had no clinical signs. Completely resected ANF (N = 57) have not recurred (median follow-up, 4.1 y; range, 0-14 y). Four ANF transformed into MPNST and 17 patients had a history of MPNST in a different location than was their ANF. Conclusions: Growth of distinct nodular lesions, pain, and FDG-PET avidity should raise concern for ANF in NF1. Patients with ANF are at greater risk for development of MPNST. Complete resection of ANF may prevent development of MPNST.
|
Authors | Christine S Higham, Eva Dombi, Aljosja Rogiers, Sucharita Bhaumik, Steven Pans, Steve E J Connor, Markku Miettinen, Raf Sciot, Roberto Tirabosco, Hilde Brems, Andrea Baldwin, Eric Legius, Brigitte C Widemann, Rosalie E Ferner |
Journal | Neuro-oncology
(Neuro Oncol)
Vol. 20
Issue 6
Pg. 818-825
(05 18 2018)
ISSN: 1523-5866 [Electronic] England |
PMID | 29409029
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Topics |
- Adolescent
- Adult
- Child
- Child, Preschool
- Female
- Humans
- Infant
- Magnetic Resonance Imaging
(methods)
- Male
- Middle Aged
- Neurofibroma
(complications, diagnostic imaging, pathology)
- Neurofibromatosis 1
(diagnostic imaging, etiology, pathology)
- Neurofibrosarcoma
(diagnostic imaging, etiology, pathology)
- Positron-Emission Tomography
(methods)
- Prognosis
- Tomography, X-Ray Computed
(methods)
- Young Adult
|